U.S. Healthcare Top Growth Stocks

Delcath Systems

Market Cap: US$472.6m

An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

Ontrak

Market Cap: US$2.3m

Operates as a value-based behavioral healthcare company in the United States.

Myomo

Market Cap: US$81.3m

A wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.

IceCure Medical

Market Cap: US$59.2m

A commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally.

TELA Bio

Market Cap: US$77.9m

A commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy.

Lifeward

Market Cap: US$10.5m

A medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.

electroCore

Market Cap: US$40.4m

A bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (“nVNS”) technology platform in the United States, the United Kingdom, and internationally.

Nuwellis

Market Cap: US$1.1m

A medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.

Co-Diagnostics

Market Cap: US$8.8m

Operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.